Trial Profile
Zinc L-carnosine complex polaprezinc for pica and polydipsia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2019
Price :
$35
*
At a glance
- Drugs Polaprezinc (Primary)
- Indications Pica
- Focus Therapeutic Use
- 31 May 2019 Status changed from recruiting to completed.
- 14 Nov 2016 Planned number of patients changed from 10 to 20.
- 11 Mar 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.